Keytruda

Moderna’s Cancer Vaccine Breakthrough Is Real. The Valuation Is Now the Harder Question.

Moderna’s personalized cancer vaccine just delivered the kind of Phase 3 result the mRNA platform needed. The science looks far more credible today. The stock price, however, now asks a.

Mehr lesen